Condition
Driving Under the Influence of Alcohol and Other Drugs
Total Trials
4
Recruiting
0
Active
4
Completed
0
Key Insights
Highlights
Treatment Research
6 treatments under study, led by Active Ethanol
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Phase 1 (4)
Trial Status
Active Not Recruiting4
Clinical Trials (4)
Showing 4 of 4 trials
NCT02404688Phase 1Active Not Recruiting
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition
NCT02709954Phase 1Active Not Recruiting
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study I
NCT02710097Phase 1Active Not Recruiting
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study II
NCT02710331Phase 1Active Not Recruiting
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III
Showing all 4 trials
Research Network
Common Treatments
- Active Ethanol2
- Active Oral Ethanol2
- Active Inhaled Cannabis1
- Active Inhaled Delta9thc1
- Active Delta9thc1
Active Sponsors
- Yale University4
Related Conditions
- Alcohol Effect4
- Cannabis4